Trial Profile
Phase I trial of IT 235 for cancer
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 04 Jul 2013
Price :
$35
*
At a glance
- Drugs IT 235 (Primary)
- Indications Cancer
- Focus Adverse reactions
- 19 Jun 2013 Planned initiation date changed to 1 Dec 2013, based on information in an Intezyne media release.
- 08 Apr 2012 New trial record